| Primary |
| Hypertension |
23.8% |
| Rheumatoid Arthritis |
19.0% |
| Tachyarrhythmia |
14.3% |
| Anaemia |
9.5% |
| Abdominal Discomfort |
4.8% |
| Hyperlipidaemia |
4.8% |
| Immunosuppressant Drug Therapy |
4.8% |
| Iron Deficiency |
4.8% |
| Osteoporosis |
4.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
4.8% |
| Restlessness |
4.8% |
|
| Lower Gastrointestinal Haemorrhage |
50.0% |
| Transaminases Increased |
50.0% |
|
| Secondary |
| Rheumatoid Arthritis |
31.5% |
| Drug Use For Unknown Indication |
13.7% |
| Hypertension |
12.3% |
| Coronary Artery Disease |
11.0% |
| Product Used For Unknown Indication |
9.6% |
| Atrial Fibrillation |
5.5% |
| Psoriasis |
5.5% |
| Psoriatic Arthropathy |
4.1% |
| Type 2 Diabetes Mellitus |
2.7% |
| Juvenile Idiopathic Arthritis |
1.4% |
| Osteoporosis Postmenopausal |
1.4% |
| Spondylitis |
1.4% |
|
| Pancytopenia |
10.5% |
| Acute Myeloid Leukaemia |
5.3% |
| Drug Ineffective |
5.3% |
| Erysipelas |
5.3% |
| Gastrointestinal Haemorrhage |
5.3% |
| Hair Disorder |
5.3% |
| Hyperglycaemia |
5.3% |
| Immune System Disorder |
5.3% |
| Pain |
5.3% |
| Pharyngitis |
5.3% |
| Pulmonary Embolism |
5.3% |
| Sinus Disorder |
5.3% |
| Staphylococcal Sepsis |
5.3% |
| Swelling |
5.3% |
| Upper Respiratory Tract Infection |
5.3% |
| Weight Decreased |
5.3% |
| Wound |
5.3% |
| Wrong Technique In Drug Usage Process |
5.3% |
|
| Concomitant |
| Rheumatoid Arthritis |
65.3% |
| Psoriatic Arthropathy |
6.1% |
| Product Used For Unknown Indication |
4.6% |
| Psoriasis |
4.0% |
| Osteoporosis |
2.6% |
| Juvenile Arthritis |
2.0% |
| Prophylaxis Against Graft Versus Host Disease |
2.0% |
| Bone Marrow Conditioning Regimen |
1.7% |
| Diabetes Mellitus |
1.4% |
| Ankylosing Spondylitis |
1.2% |
| Drug Use For Unknown Indication |
1.2% |
| Gastritis Erosive |
1.2% |
| Vitamin C Deficiency |
1.2% |
| Atrial Fibrillation |
0.9% |
| Hypertension |
0.9% |
| Juvenile Idiopathic Arthritis |
0.9% |
| Osteopenia |
0.9% |
| Osteoporosis Postmenopausal |
0.9% |
| Arthritis |
0.6% |
| Bronchial Hyperreactivity |
0.6% |
|
| Rheumatoid Arthritis |
21.3% |
| Drug Ineffective |
7.9% |
| Pain In Extremity |
7.9% |
| Histiocytosis Haematophagic |
6.7% |
| Iridocyclitis |
5.6% |
| Aspartate Aminotransferase Increased |
4.5% |
| Liver Function Test Abnormal |
4.5% |
| Upper Respiratory Tract Infection |
4.5% |
| Vomiting |
4.5% |
| Decreased Immune Responsiveness |
3.4% |
| Malaise |
3.4% |
| Myocardial Infarction |
3.4% |
| Paraesthesia |
3.4% |
| Pyrexia |
3.4% |
| Rash |
3.4% |
| Rhinorrhoea |
3.4% |
| Cerebrovascular Accident |
2.2% |
| Chronic Obstructive Pulmonary Disease |
2.2% |
| Death |
2.2% |
| Diarrhoea |
2.2% |
|
